 |
|
Remission in Children With Hyperthyroidism Treated With PropylthiouracilLong-term Results
Christopher Gorton, MD;
Abdollah Sadeghi-Nejad, MD;
Boris Senior, MD
Am J Dis Child. 1987;141(10):1084-1086.
Abstract
• We treated 69 hyperthyroid children with propylthiouracil, of whom 53 remained under surveillance. Of these children, 34 (64%) had an Initial remission, but relapses were frequent (47%). At this writing, 24 patients (45%) were in remission, with a mean duration of remission of 55 months (range, ten to 132 months). We found that the triiodothyronine level took significantly longer than the thyroxine (T4) level to return to normal. Thus, based on the T4 level alone, treatment may have been stopped prematurely in some patients, causing the relapse rate to be falsely high. The response to therapy did not depend on the size of the goiter nor on the Initial levels of T4 or triiodothyronine. Six patients had adverse reactions, which were serious in two patients.
(AJDC 1987;141:1084-1086)
Author Affiliations
From the Department of Pediatrics, Tufts University School of Medicine, Pediatric Endocrine Metabolic Service, New England Medical Center (Boston Floating Hospital for Children).
Footnotes
Accepted for publication April 16, 1987.
Reprint requests to Tufts University School of Medicine, New England Medical Center, 750 Washington St, Boston, MA 02111 (Dr Senior).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Approach to the Pediatric Patient with Graves' Disease: When Is Definitive Therapy Warranted?
Bauer
J. Clin. Endocrinol. Metab. 2011;96:580-588.
ABSTRACT
| FULL TEXT
Predicting the Likelihood of Remission in Children With Graves' Disease: A Prospective, Multicenter Study
Glaser et al.
Pediatrics 2008;121:e481-e488.
ABSTRACT
| FULL TEXT
|
